Avoro Capital Advisors LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001633313

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 46 positions · Total reported value $6.41B · Top-10 concentration 70.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 62.1% · 3 new · 15 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -15.9% · vs SPY -18.0% · Prev Value $11.14B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.4% · vs SPY -2.6% · Latest Value $9.67B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, Avoro Capital Advisors LLC disclosed 46 equity positions with a combined reported value of $6.41B. The filing implies a focused portfolio: its ten largest positions account for 70.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were HZNP ($809.83M), UTHR ($644.29M), ARGX ($491.63M). By sector, the heaviest allocations are Health Care 60.5%, Other 39.5%.

Versus the prior quarter, Avoro Capital Advisors LLC opened 3 new positions, trimmed 15 and fully exited 0, a turnover rate of 62.1% of positions.

The largest new positions opened in Q3 2023 were HZNP ($809.83M), UTHR ($644.29M), ARGX ($491.63M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • HZNP HORIZON THERAPEUTICS PUB L · $809.83M
  • UTHR UNITED THERAPEUTICS CORP DEL · $644.29M
  • ARGX ARGENX SE · $491.63M
  • SRPT SAREPTA THERAPEUTICS INC · $487.91M
  • APLS APELLIS PH · $422.67M
  • SGEN SEAGEN INC · $373.30M
  • ASND ASCENDIS PHARMA A/S · $343.66M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $340.65M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Avoro Capital Advisors LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-28 Buy Scribe Therapeutics, Inc. 7,905 $18.25 SEC filing
2026-07-24 Buy Scribe Therapeutics, Inc. 50,000 $22.31 SEC filing
2026-07-24 Buy Scribe Therapeutics, Inc. 2,333,333 $15.00 SEC filing

All insider transactions →

Fund Profile

Avoro Capital Advisors LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 26 US equity positions with a combined value of $11.14B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-74391 (status: Approved), registered 2012-03-30
  • Regulatory AUM (Form ADV): $13.55B as of 2026-03-05
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: avorocapital.com

Portfolio Structure

  • 26 positions · $11.14B reported value (Q2 2026)
  • Top 10 holdings = 79.5% of reported value
  • Largest position: UTHR (UNITED THERAPEUTICS CORP DEL) at 13.5%
  • Average position size: $428.32M

Sector Tilt

  • Health Care 99.7%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 2 new, 12 added, 3 reduced, 6 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 60.5%
Other 39.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 7.00M $809.83M 12.63%
12.63%
New
2 2.85M $644.29M 10.05%
10.05%
New
3 1.00M $491.63M 7.67%
7.67%
New
4 4.03M $487.91M 7.61%
7.61%
New
5 11.11M $422.67M 6.59%
6.59%
New
6 1.76M $373.30M 5.82%
5.82%
New
7 3.67M $343.66M 5.36%
5.36%
New
8 3.85M $340.65M 5.31%
5.31%
New
9 27.40M $333.18M 5.20%
5.20%
New
10 2.57M $297.60M 4.64%
4.64%
New
11 6.67M $290.40M 4.53%
4.53%
New
12 1.55M $227.09M 3.54%
3.54%
New
13 1.01M $179.07M 2.79%
2.79%
New
14 4.90M $167.38M 2.61%
2.61%
New
15 10.30M $153.57M 2.40%
2.40%
New
16 2.00M $114.00M 1.78%
1.78%
New
17 11.55M $81.77M 1.27%
1.27%
New
18 4.65M $54.33M 0.85%
0.85%
New
19 3.85M $53.58M 0.84%
0.84%
New
20 1.50M $53.48M 0.83%
0.83%
New
21 1.00M $50.42M 0.79%
0.79%
New
22 812.50K $37.35M 0.58%
0.58%
New
23 9.00M $37.17M 0.58%
0.58%
New
24 2.56M $37.11M 0.58%
0.58%
New
25 6.70M $30.48M 0.47%
0.47%
New
26 555.55K $28.10M 0.44%
0.44%
New
27 2.98M $27.18M 0.42%
0.42%
New
28 1.25M $25.61M 0.40%
0.40%
New
29 3.15M $25.36M 0.40%
0.40%
New
30 2.22M $25.02M 0.39%
0.39%
New
31 4.54M $21.72M 0.34%
0.34%
New
32 955.55K $20.86M 0.33%
0.33%
New
33 3.00M $18.42M 0.29%
0.29%
New
34 2.51M $16.01M 0.25%
0.25%
New
35 565.00K $15.18M 0.24%
0.24%
New
36 2.85M $13.79M 0.21%
0.21%
New
37 3.92M $12.40M 0.19%
0.19%
New
38 2.95M $11.48M 0.18%
0.18%
New
39 444.44K $10.48M 0.16%
0.16%
New
40 1.20M $9.01M 0.14%
0.14%
New
41 1.64M $7.10M 0.11%
0.11%
New
42 2.50M $5.95M 0.09%
0.09%
New
43 2.06M $2.84M 0.04%
0.04%
New
44 500.00K $1.41M 0.02%
0.02%
New
45 500.00K $1.22M 0.02%
0.02%
New
46 11.46K $140.36K 0.00%
0.00%
New

FAQ

What did Avoro Capital Advisors LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, Avoro Capital Advisors LLC reported 46 equity positions worth $6.41B in aggregate; its largest disclosed positions were HZNP ($809.83M), UTHR ($644.29M), ARGX ($491.63M).

How large is Avoro Capital Advisors LLC's portfolio?

Avoro Capital Advisors LLC reported $6.41B of long equity holdings across 46 positions as of 2023-Q3. Top-10 holdings account for 70.9% of reported value.

What is Avoro Capital Advisors LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/avoro-capital-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →